Trial Profile
A prospective, single-center, randomized, double-blinded, placebo controlled, dose finding clinical phase I study investigating APO-2 for wound healing
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2016
Price :
$35
*
At a glance
- Drugs Apoptotic blood mononuclear cell therapy (Primary)
- Indications Wounds
- Focus Adverse reactions
- Acronyms Marsyas I
- 09 Mar 2016 New trial record